Full Text View
Tabular View
No Study Results Posted
Related Studies
Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion (RAFFAELLO)
This study is ongoing, but not recruiting participants.
Study NCT01534962   Information provided by Menarini Group

First Received on February 10, 2012.   Last Updated on June 4, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Persistent Atrial Fibrillation
Additional conditions recognized in this trial
Atrial Fibrillation
More general conditions related to this trial
Arrhythmias, Cardiac
Cardiovascular Diseases
Heart Diseases
Pathologic Processes
Interventions listed in this trial
Ranolazine
Placebo
More general drug interventions related to this trial
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Sponsors listed in this trial
Menarini Group


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services